BACKGROUND: Nutcracker esophagus (NE) is a manometric finding defined by peristaltic contractions with a mean distal esophageal amplitude (DEA) >180 mm Hg. This threshold has been selected as it exceeds the average DEA in healthy volunteers by 2 SDs. Since its introduction the clinical significance of this finding has been challenged, as many patients with NE are asymptomatic. AIM: To evaluate whether defining NE based on a different DEA threshold would be clinically more meaningful. METHODS: Retrospective review of prospectively collected manometry data between October 2001 and December 2003. Using previously published normal DEA values (mean and SD) patients with NE were stratified into 3 groups: group A (2 to 3 SD above mean): DEA 180 to 220 mm Hg; group B (3 to 4 SD above mean): DEA 220 to 260 mm Hg; and group C (>4 SD above mean): DEA >260 mm Hg. Symptoms, esophageal acid exposure, bolus transit data, and lower esophageal sphincter data were reviewed. RESULTS: The stratification of 56 NE patients into groups A, B, and C were 31, 16, and 9, respectively. The proportion of patients presenting with chest pain increased from 23% in group A to 69% in group B and 100% in group C. Patients in group C had significantly (P<0.05) higher mean lower esophageal sphincter pressure, shorter bolus transit time, and lower frequency of abnormal reflux. CONCLUSIONS: A revised definition of NE to include patients with a DEA >260 mm Hg, and possibly those with >220 may have greater clinical relevance.
BACKGROUND: Nutcracker esophagus (NE) is a manometric finding defined by peristaltic contractions with a mean distal esophageal amplitude (DEA) >180 mm Hg. This threshold has been selected as it exceeds the average DEA in healthy volunteers by 2 SDs. Since its introduction the clinical significance of this finding has been challenged, as many patients with NE are asymptomatic. AIM: To evaluate whether defining NE based on a different DEA threshold would be clinically more meaningful. METHODS: Retrospective review of prospectively collected manometry data between October 2001 and December 2003. Using previously published normal DEA values (mean and SD) patients with NE were stratified into 3 groups: group A (2 to 3 SD above mean): DEA 180 to 220 mm Hg; group B (3 to 4 SD above mean): DEA 220 to 260 mm Hg; and group C (>4 SD above mean): DEA >260 mm Hg. Symptoms, esophageal acid exposure, bolus transit data, and lower esophageal sphincter data were reviewed. RESULTS: The stratification of 56 NE patients into groups A, B, and C were 31, 16, and 9, respectively. The proportion of patients presenting with chest pain increased from 23% in group A to 69% in group B and 100% in group C. Patients in group C had significantly (P<0.05) higher mean lower esophageal sphincter pressure, shorter bolus transit time, and lower frequency of abnormal reflux. CONCLUSIONS: A revised definition of NE to include patients with a DEA >260 mm Hg, and possibly those with >220 may have greater clinical relevance.
Authors: Sabine Roman; John E Pandolfino; Joan Chen; Lubomyr Boris; Daniel Luger; Peter J Kahrilas Journal: Am J Gastroenterol Date: 2011-09-20 Impact factor: 10.864
Authors: Dustin A Carlson; Karthik Ravi; Peter J Kahrilas; C Prakash Gyawali; Arjan J Bredenoord; Donald O Castell; Stuart J Spechler; Magnus Halland; Navya Kanuri; David A Katzka; Cadman L Leggett; Sabine Roman; Jose B Saenz; Gregory S Sayuk; Alan C Wong; Rena Yadlapati; Jody D Ciolino; Mark R Fox; John E Pandolfino Journal: Am J Gastroenterol Date: 2015-06-02 Impact factor: 10.864
Authors: Daniel Pohl; Jody Ciolino; Jason Roberts; Edoardo Savarino; Janice Freeman; Paul J Nietert; Radu Tutuian; Donald Castell Journal: Dig Liver Dis Date: 2012-04-03 Impact factor: 4.088